Skip to content
PT
Company

Updated:

Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001661460, and its reported...

Overview

Poseida Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001661460, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2024-03-07, it reported annual revenue of USD 64,703,000; net income of USD -123,430,000; total assets of USD 273,885,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Poseida Therapeutics, Inc.
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
San Diego, CA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001661460

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2023USD$64.7M-$123.4M$273.9M$44.5M-$92.2M
FY2022USD$130.5M-$64.0M$351.8M$81.4M-$26.8M
FY2021USD$31.2M-$125.0M$269.3M$206.3M-$102.5M
FY2020USD—-$129.8M$371.5M$84.0M-$113.3M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
8-K8-K
8-K8-K
SC 13G—Form SC 13G
10-Q10-Q
8-K8-K
SC 13G—Form SC 13G
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K
10-Q10-Q

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Poseida Therapeutics, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Poseida Therapeutics, Inc. | San Diego Company | Altss